Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study. [electronic resource]
Producer: 20121031Description: 79 p. digitalISSN:- 1479-5876
- Adult
- Aged
- Cell Line, Tumor
- Cell Survival -- drug effects
- DNA Damage
- Deoxycytosine Nucleotides -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Enzyme Inhibitors -- pharmacology
- Female
- Gynecology
- Histones -- metabolism
- Humans
- Immunoblotting
- Medical Oncology
- Middle Aged
- Ovarian Neoplasms -- drug therapy
- Platinum -- adverse effects
- Pyridines -- pharmacology
- Ribonucleotide Reductases -- antagonists & inhibitors
- Thiosemicarbazones -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.